Surviving premature babies in Malawi continue to have poor growth rates and development delay

Press release 8 Nov 2011
19

Surviving premature babies in Malawi continue to have poor growth rates and development delay

A detailed study from Malawi, published in this week’s PLoS Medicine, shows that during the first 2 years of life, infants who were born prematurely (before 37 weeks gestation) continue to have a higher risk of death than infants born at term and are also more likely to have poorer growth and developmental delay.

The authors, led by Nynke Van Den Broek from the Liverpool School of Tropical Medicine, and Melissa Gladstone, from the University of Liverpool say that their findings show that in addition to interventions in the immediate neonatal period, a focus on early childhood is needed to improve outcomes for infants
born prematurely in low-income settings. 

In their study of 2,297 pregnant women in southern Malawi, the authors compared 247 infants born preterm with 593 infants born at term and found that premature infants were 1.79 times more likely to die than term infants: 27 (10.9%) preterm babies died compared to 37/593 (6.2%) term babies. Furthermore, at 12, 18, and 24 months follow up, the authors found that surviving preterm infants were more likely to be underweight and have higher rates of disability and developmental delay.

The authors say: “To date, interventions in low-income settings to reduce neonatal morbidity and mortality have targeted the perinatal period. Our data show that, for preterm babies who survive the immediate neonatal period, there is ongoing disadvantage with increased risk of death, growth retardation, and developmental delay.”

They continue: “Further detailed qualitative and longitudinal studies to assess the causal mechanisms for these problems would be extremely beneficial. Along with these studies, post-neonatal interventions need to be trialled that might improve outcomes in this group of preterm born children.”

Funding

This study was funded by the Wellcome Trust (project grant 065810/Z/01/Z) http://www.wellcome.ac.uk/Funding/International/Global-health-research/i... funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests

The authors have declared that no competing interests exist.

Citation

Gladstone M, White S, Kafulafula G, Neilson JP, van den Broek N (2011) Post-neonatal Mortality, Morbidity, and Developmental Outcome after Ultrasound-Dated Preterm Birth in Rural Malawi: A Community-Based Cohort Study. PLoS Med 8(11): e1001121. doi:10.1371/journal.pmed.1001121

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001121

PRESS-ONLY PREVIEW OF THE ARTICLE

http://www.plos.org/media/press/2011/plme-08-11-gladstone.pdf

CONTACT

Melissa Gladstone
University of Liverpool
Institute of Child Health, School of Reproductive and Developmental Medicine
Alder Hey Children's NHS Foundation Trust
Eaton Road
Liverpool, Merseyside L12 2AP
United Kingdom
M.J.Gladstone@liverpool.ac.ukmgladstone@btinternet.com

Nynke Van Den Broek
Maternal & Newborn Health Unit
Liverpool School of Tropical Medicine
Pembroke Place
Liverpool, L35QA
United Kingdom
vdbroek@liverpool.ac.uk 

Everything published by PLoS Medicine is Open Access: freely available for anyone to read, download, redistribute and otherwise use, as long as the authorship is properly attributed. Please mention PLoS Medicine in your report and use the links below to take your readers straight to the online articles:

  • Combination drugs for treatment of uncomplicated malaria in African children
  • XPert MTB/RIF cost effective for TB diagnosis in low and middle income settings
  • Surviving premature babies in Malawi continue to have poor growth rates and development
  • delay
  • How do we manage the demand for global health education?
  • For information about PLoS Medicine relevant to journalists, bloggers and press officers,
  • including an outline of our approach to the media, our embargo policy, and how you can re-use

PLoS Medicine material, see the Speaking of Medicine blog: 
http://speakingofmedicine.plos.org/media/ 

About PLoS Medicine

PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visithttp://www.plos.org